Insider · CIK 0001789335

Chan Mitchell

Reports to the SEC for 3 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001789335

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	RGNXREGENXBIO Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−4,902 sh	$9.32	−$45.7K	122,815
2026-05-06	AVTXAvalo Therapeutics, Inc.S Sale	Director	SSale	−3,167 sh	$22.88	−$72.5K	3,166
2026-03-28	AVTXAvalo Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,166 sh	—	—	3,167
2026-03-28	AVTXAvalo Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,166 sh	—	—	6,333
2026-01-06	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+39.7K sh	—	—	39,650
2026-01-06	RGNXREGENXBIO Inc.A Award	Chief Financial Officer	AAward	+73.7K sh	—	—	127,717
2025-09-01	RGNXREGENXBIO Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−4,901 sh	$8.93	−$43.8K	53,968
2025-06-17	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.1K sh	—	—	20,100
2025-03-28	AVTXAvalo Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,167 sh	—	—	3,167
2025-03-28	AVTXAvalo Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,167 sh	—	—	6,333
2025-01-02	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+62.5K sh	—	—	62,547
2024-09-16	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+289K sh	—	—	289,362
2024-09-16	RGNXREGENXBIO Inc.A Award	Chief Financial Officer	AAward	+58.9K sh	—	—	58,869
2024-08-13	AVTXAvalo Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+9,500 sh	—	—	9,500
2024-08-13	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24.6K sh	—	—	24,600
2023-12-20	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,334 sh	—	—	3,334
2022-06-14	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-12-01	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+80K sh	—	—	80,000
2021-03-15	Viela Bio, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−30K sh	—	—	0
2021-03-15	Viela Bio, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−13K sh	—	—	0
2021-03-15	Viela Bio, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−50.1K sh	—	—	0
2021-03-15	Viela Bio, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−67.5K sh	—	—	0
2021-03-13	Viela Bio, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−37.5K sh	$53.00	−$1.99M	0
2020-03-02	Viela Bio, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50.1K sh	—	—	50,056

Recent filings

Accepted (ET)
Sep 34
Chan Mitchell0001789335-26-000008
SEC(opens sec.gov)
May 74
Chan Mitchell0001789335-26-000006
SEC(opens sec.gov)
Mar 314
Chan Mitchell0001789335-26-000004
SEC(opens sec.gov)
Jan 84
Chan Mitchell0001789335-26-000002
SEC(opens sec.gov)
Sep 34
Chan Mitchell0001562180-25-006078
SEC(opens sec.gov)
Jun 184
Chan Mitchell0001578563-25-000324
SEC(opens sec.gov)
Apr 14
Chan Mitchell0001578563-25-000204
SEC(opens sec.gov)
Jan 64
Chan Mitchell0001562180-25-000187
SEC(opens sec.gov)
Sep 184
Chan Mitchell0001562180-24-006869
SEC(opens sec.gov)
Aug 144
Chan Mitchell0001578563-24-000369
SEC(opens sec.gov)
Dec 214
Chan Mitchell0001628280-23-042490
SEC(opens sec.gov)
Jun 154
Chan Mitchell0001578563-22-000021
SEC(opens sec.gov)
Dec 34
Chan Mitchell0001878930-21-000010
SEC(opens sec.gov)
Mar 154
Chan Mitchell0000899243-21-011500
SEC(opens sec.gov)

Companies

Address

C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850